Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1085/week)
    • Manufacturing(525/week)
    • Energy(409/week)
    • Technology(998/week)
    • Other Manufacturing(318/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

BioMarin Pharmaceutical Inc.

Jun 24, 2025
BioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 Congress
May 16, 2025
BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
May 12, 2025
BioMarin Presents New Data for VOXZOGO® (vosoritide) in Children with Achondroplasia and Other Skeletal Conditions at Two International Endocrinology Meetings
May 01, 2025
BioMarin Reports First Quarter 2025 Results and Reaffirms Full-year Guidance
Apr 02, 2025
BioMarin Announces Positive Pivotal Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria
Feb 24, 2025
BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors
Feb 19, 2025
BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance
Feb 05, 2025
BioMarin to Host Fourth Quarter and Full-Year 2024 Financial Results Conference Call and Webcast on Wednesday, February 19, 2025, at 4:30pm ET
Jan 13, 2025
BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court
Jan 06, 2025
BioMarin to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 9:00 am PT / 12:00 pm ET, in San Francisco, CA
Nov 16, 2024
BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
Oct 29, 2024
BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook
Sep 04, 2024
BioMarin Holds Investor Day; Provides New Corporate Strategy and Introduces 2027 Financial Guidance
Sep 04, 2024
BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time
Aug 29, 2024
BioMarin to Present at the 22nd Annual Morgan Stanley Global Healthcare Conference on Thursday, September 5 at 7:45 AM PT / 10:45 AM ET in New York, NY
Aug 21, 2024
BioMarin Announces New R&D and Business Development Leadership
Aug 19, 2024
BioMarin to Host 2024 Investor Day on September 4th in New York
Jun 17, 2024
BioMarin to Present Data Highlighting Significant Impact of VOXZOGO® (vosoritide) in Bone Health and Health-Related Quality of Life in Achondroplasia at 2024 International Conference on Children's Bone Health
May 08, 2024
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV
Mar 12, 2024
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
  •  
  • Page 1
  • ››

Latest News

Jun 26, 2025

Worthington Steel Declares Quarterly Dividend

Jun 26, 2025

CPSI Certifications Launches ISO/IEC 42001:2023 Artificial Intelligence Management Systems Certification...

Jun 26, 2025

Unit Dose Packaging Market Projected to Reach USD 48.20 Billion by 2030: Unpacking Innovation and Regulatory...

Jun 26, 2025

Tunnel Boring Machine Industry Report 2025: Smart Technology Integration Drives Innovations - Size and Trends...

Jun 26, 2025

McDonald Electrical Corporation Announces Acquisition of ANJ Electric, Expanding Regional Footprint and...

Jun 26, 2025

American Rebel Light Beer Recaps Successful Title Sponsorship of American Rebel Light Virginia NHRA Nationals

Jun 26, 2025

Data Center Poll: Operators Cite Higher-Efficiency Cooling Systems as Top Strategy for Reducing Power...

Jun 26, 2025

IFF’s 2024 Do More Good Report Highlights Progress in Sustainability and Innovation

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia